BiostockSynartro Reports LPLV in Phase I/IIa Study
Synartro announces the last participant's last visit in the Phase I/IIa clinical trial of SYN321, an intra-articular treatment for knee osteoarthritis. Initiated in August 2025, the study involved 35 participants across four cohorts to evaluate safety, tolerability, PK, and early efficacy.